Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
| Autor: | Chan, A.T.C., Lee, V.H.F., Hong, R.-L., Ahn, M.-J., Chong, W.Q., Kim, S.-B., Ho, G.F., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Aziz, M.A.S.A., Ng, Q.S., Yen, C.-J., Soparattanapaisarn, N., Ngan, R.K.-C., Kho, S.K., Tiambeng, M.L.A., Yun, T., Sriuranpong, V., Algazi, A.P., Cheng, A., Massarelli, E., Swaby, R.F., Saraf, S., Yuan, J., Siu, L.L. |
|---|---|
| Zdroj: | In Annals of Oncology March 2023 34(3):251-261 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|